Function
Locations
Delivers cholesterol to the inner membrane for CYP11A1; the acute (minutes-scale) rate-limiting control point of steroid output. Deficiency = congenital lipoid CAH.
Adrenal steroidogenesis converts cholesterol into the three classes of steroid hormone — glucocorticoids (cortisol), mineralocorticoids (aldosterone) and adrenal androgens (DHEA, androstenedione) — through a branched network of mitochondrial and endoplasmic-reticulum enzymes. The acute, rate-limiting step is the delivery of cholesterol from the outer to the inner mitochondrial membrane by the steroidogenic acute regulatory protein STAR; there the side-chain-cleavage cytochrome P450 CYP11A1 (P450scc) makes pregnenolone, the common precursor of all steroid hormones. Pregnenolone is then routed by two ER enzymes whose order and combination select the branch: the 3beta-hydroxysteroid dehydrogenase/isomerase HSD3B2 (Delta5 -> Delta4, giving progesterone, 17-hydroxyprogesterone or androstenedione) and the bifunctional 17alpha-hydroxylase/17,20-lyase CYP17A1 (17-hydroxylation commits to cortisol; the 17,20-lyase reaction commits to androgens). 21-hydroxylase CYP21A2 then hydroxylates progesterone -> 11-deoxycorticosterone (mineralocorticoid branch) and 17-hydroxyprogesterone -> 11-deoxycortisol (glucocorticoid branch). The final oxidations return to the mitochondrion: CYP11B1 (11beta-hydroxylase) makes cortisol, while its close paralog CYP11B2 (aldosterone synthase), uniquely possessing 18-hydroxylase/18-oxidase activity, converts deoxycorticosterone through corticosterone and 18-hydroxycorticosterone to aldosterone in the zona glomerulosa. Inherited defects define the congenital adrenal hyperplasias and related disorders: STAR (congenital lipoid adrenal hyperplasia), CYP11A1 (adrenal insufficiency), HSD3B2 (3beta-HSD-deficiency CAH), CYP17A1 (combined 17alpha- hydroxylase/17,20-lyase deficiency), CYP21A2 (21-hydroxylase deficiency, >90% of CAH), CYP11B1 (11beta-hydroxylase-deficiency CAH) and CYP11B2 (aldosterone synthase / CMO deficiency; a CYP11B1/B2 chimera causes glucocorticoid-remediable aldosteronism).
All recommended fields populated.
✗ none found
No MODULE:adrenal_steroidogenesis deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
7 complete review(s) · 0 with deep research · 0 missing review · 7 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| CYP11A1 P05108 | ✓ | ✓ | ✗ |
| CYP11B1 P15538 | ✓ | ✓ | ✗ |
| CYP11B2 P19099 | ✓ | ✓ | ✗ |
| CYP17A1 P05093 | ✓ | ✓ | ✗ |
| CYP21A2 P08686 | ✓ | ✓ | ✗ |
| HSD3B2 P26439 | ✓ | ✓ | ✗ |
| STAR P49675 | ✓ | ✓ | ✗ |
Adrenal steroidogenesis grounded to the human enzymes STAR (UniProtKB:P49675, GO:0120020, cholesterol transfer), CYP11A1 (P05108, GO:0008386, EC 1.14.15.6), HSD3B2 (P26439, GO:0003854/GO:0004769, EC 1.1.1.145), CYP17A1 (P05093, GO:0004508, EC 1.14.14.19), CYP21A2 (P08686, GO:0004509, EC 1.14.14.16), CYP11B1 (P15538, GO:0004507, EC 1.14.15.4) and CYP11B2 (P19099, GO:0047783/GO:0004507, EC 1.14.15.4). GO molecular-function and location terms were taken from the completed human gene reviews and verified against the local go.db; Reactome reaction ids/titles were verified against the local reactome cache. Each step uses a PANTHER family selector with the human enzyme as representative so the module generalises across orthologs/paralogs: CYP11A1/CYP11B1/CYP11B2 share the mitochondrial P450 family PTHR24279, and CYP17A1/CYP21A2 share the microsomal P450 clade PTHR24289. The pathway is branched, not linear: the Delta4 (via HSD3B2 first) and Delta5 (via CYP17A1 first) routes interconvert, CYP17A1 selects cortisol (17-hydroxylase) vs androgen (17,20-lyase) fate, and CYP21A2 feeds both the mineralocorticoid (DOC->CYP11B2->aldosterone) and glucocorticoid (11-deoxycortisol->CYP11B1-> cortisol) endpoints. Gonadal/peripheral sex-steroid steps (CYP19A1 aromatase, SRD5A2 5alpha-reductase) and the cortisol/cortisone shuttle (HSD11B1/HSD11B2) are a separate module. Disorders span the pathway: lipoid CAH (STAR), adrenal insufficiency (CYP11A1), 3beta-HSD CAH (HSD3B2), 17OHD (CYP17A1), 21-hydroxylase-deficiency CAH (CYP21A2, >90%), 11beta-OHD CAH (CYP11B1), and aldosterone-synthase/CMO deficiency and glucocorticoid-remediable aldosteronism (CYP11B2).
Delivers cholesterol to the inner membrane for CYP11A1; the acute (minutes-scale) rate-limiting control point of steroid output. Deficiency = congenital lipoid CAH.
First and rate-limiting enzymatic step; produces the pregnenolone common precursor of all steroid hormones. Deficiency = adrenal insufficiency.
Obligatory Delta5->Delta4 conversion common to all three hormone branches; also acts on 17OH-pregnenolone and DHEA. Deficiency = 3beta-HSD-deficiency CAH.
Branch point: 17-hydroxylation routes toward cortisol; 17,20-lyase routes toward androgens/estrogens. Deficiency = combined 17alpha-hydroxylase/17,20-lyase deficiency.
Supplies both the mineralocorticoid (DOC) and glucocorticoid (11-deoxycortisol) branches. Deficiency is the commonest cause of CAH (>90%).
Glucocorticoid endpoint; 11beta-hydroxylates 11-deoxycortisol to cortisol. Deficiency = 11beta-hydroxylase-deficiency CAH (second commonest CAH).
Mineralocorticoid endpoint in the zona glomerulosa; uniquely completes the 18-oxidation to aldosterone. Deficiency = aldosterone synthase (CMO) deficiency.